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Abstract 
 
Objective. To determine whether a single session of exercise is sufficient to induce cerebral 
adaptations in individuals with Huntington’s disease, and explore the time dynamics of any 
acute cerebrovascular response.  
Methods. In this case-control study we employed arterial-spin labelling magnetic resonance 
imaging in 19 HD gene-positive participants (32-65 years old, 13 males) and 19 controls (29-
63 years old, 10 males) matched for age, gender, body mass index and self-reported activity 
levels, to measure global and regional perfusion in response to 20-minutes of moderate-
intensity cycling. Cerebral perfusion was measured at baseline and 15-, 40- and 60-minutes 
after exercise cessation.  
Results. Relative to baseline, cerebral perfusion increased in HD patients yet was unchanged 
in control participants in the precentral gyrus, middle frontal gyrus and hippocampus 40-
minutes after exercise cessation (+15 to +32.5% change in HD participants, -7.7 to 0.8% 
change in controls). CAG repeat length predicted the change in the precentral gyrus, and the 
intensity of the exercise intervention predicted hippocampal perfusion change in HD 
participants. In both groups, exercise increased hippocampal blood flow 60-minutes after 
exercise cessation.  
Conclusions. Here we demonstrate the utility of acute exercise as a clinically sensitive 
experimental paradigm to modulate the cerebrovasculature. Twenty minutes of aerobic 
exercise induced transient cerebrovascular adaptations in the hippocampus and cortex 
selectively in HD participants and likely represents latent neuropathology not evident at rest.  
 
 
  
 Introduction 
Huntington's disease (HD) is a progressive neurodegenerative disorder caused by the 
expansion of a polyglutamine stretch within the Huntingtin gene (Gusella et al., 1993; 
Vonsattel and DiFiglia, 1998). Neuropathology in HD causes cognitive dysfunction, 
psychiatric symptoms, and a movement disorder characterized by involuntary movements and 
impaired motor control (Bates et al., 2002). The availability of genetic testing means at-risk 
HD family members can be identified early in the disease course and prior to the onset of 
symptoms. As a result, there is a drive to discover the earliest signs of neuropathology that can 
guide future therapeutics. 
  Current evidence suggests that long-term exercise interventions can produce functional 
improvements in a range of populations. Exercise studies using genetic mouse models of HD 
have produced promising results, with converging evidence showing an improvement, or delay, 
in the emergence of motor impairments (van Dellen et al., 2000, 2008; Pang et al., 2006; 
Harrison et al., 2013; Herbst and Holloway, 2015). Similarly a systematic review of 18 HD 
patient studies found evidence for beneficial effects of exercise on motor function, gait speed 
and balance (Fritz et al., 2017). Despite this, the mechanisms supporting these exercise-induced 
functional improvements in HD are unclear.  
Evidence for a beneficial effect of exercise on HD neuropathology is largely limited to 
genetic rodent models of HD and remains equivocal. A reduction in striatal neuropathology 
has been observed in some studies (Pang et al., 2006; Harrison et al., 2013), whilst others have 
shown no effect of exercise on the degree of atrophy or mHtt aggregation (van Dellen et al., 
2008). In a small patient study, a 9-month multi-disciplinary rehabilitation intervention which 
included exercise as a component increased brain volume in the grey matter, caudate and 
prefrontal cortex and improve cognition, although the independent contribution of exercise was 
not determined (Cruickshank et al., 2015). 
Inconsistencies across studies in the type, dose and duration of exercise likely 
contribute to discrepancies in the literature and may be masking the therapeutic potential of 
exercise in HD. To address this, a focused investigation of the temporal dynamics of exercise 
is needed. Emerging evidence suggests regional exercise effects on the brain may overlap in 
terms of acute and long-term timescales (Weng et al., 2017). For example, in healthy adults, a 
single exercise session has been shown to improve motor function (Mang et al., 2014; Skriver 
et al., 2014) improve cognition (Winter et al., 2007; Coles and Tomporowski, 2008; Chang et 
al., 2012; Roig et al., 2012; Jo et al., 2018), increase peripheral neurotrophin and catecholamine 
biomarkers (Winter et al., 2007; Mang et al., 2014; Skriver et al., 2014) and alter cerebral 
perfusion (Smith et al., 2010; MacIntosh et al., 2014; Steventon et al., 2019). However, it is 
not clear whether the cerebrovascular response to the physiological provocation of exercise 
will be the same in a disease group where resting perturbations in the vascular system are 
present. In HD, structural and functional cerebral vascular abnormalities have been shown(Vis 
et al., 1998; Lin et al., 2013; Rahman et al., 2013; Hua et al., 2014; Drouin-Ouellet et al., 2015; 
Hsiao et al., 2015; St-Amour et al., 2015) and aggregation of mutant Huntingtin is present in 
the neurovascular unit(Drouin-Ouellet et al., 2015) which may affect the ability of the vascular 
system to respond to the demands of acute exercise.  
The current study is the first to examine the cerebrovascular response to a single session 
of exercise in HD. Previous work has shown an altered peripheral response during and 
following exercise (Steventon et al., 2018), with metabolic and cardiorespiratory deficits found 
to reduce exercise performance and affect exercise recovery. 
 Arterial spin labelling (ASL) MRI is a quantitative, non-invasive method to measure 
tissue perfusion and uses magnetically labelled arterial blood water protons as an endogenous 
tracer. ASL MRI has been shown to be a reliable and repeatable method for quantifying tissue 
perfusion in aged and clinical populations(Kilroy et al., 2014), and has been shown to be 
sufficiently sensitive to detect transient perfusion changes after exercise cessation in healthy 
populations (Smith et al., 2010; MacIntosh et al., 2014; Steventon et al., 2019). In stroke 
patients – a patient cohort where baseline cerebrovascular perturbations are evident - 20-
minutes of low and moderate intensity cycling resulted in an intensity-dependent change in 
perfusion in the somatosensory cortex using ASL-MRI, along with an intensity-independent 
response in the basal ganglia (Robertson et al., 2015).  
 Here we examined the effect of exercise on the cerebrovasculature to establish if the 
acute response to a single session of exercise is different in HD. Our primary hypothesis was a 
differential effect of exercise on CBF in HD patients compared to controls, based on evidence 
of cerebrovascular abnormalities in HD (Drouin-Ouellet et al., 2015) and an altered 
cardiorespiratory response to submaximal exercise (Steventon et al., 2018) .  
Methods 
The study design is detailed in Figure 1. 
Participants 
HD gene-positive participants (CAG length greater than or equal to 36, n = 19) were recruited 
from the South Wales HD research and management clinic, based in Cardiff, along with19 
healthy age matched controls. Gene carriers included participants in the pre-manifest (N=8) 
and manifest stages of disease (Stage I N=3; Stage II N=5; Stage III N=3). Premanifest  
participants are those that have not yet met traditional motor criteria for a diagnosis of HD, 
based on a Diagnostic Confidence Level rating of “4” according to the motor assessment 
section of the Unified HD Rating Scale (UHDRS). Manifest disease stages are based on total 
functional capacity (TFC) score on the UHDRS as defined previously (Shoulson and Fahn, 
1979). Demographic and clinical data are shown in Table 1. All participants had a stable 
medication regime, defined as unchanged for four weeks. Exclusion criteria included any 
physical or psychiatric condition that would prohibit the participant from completing the 
exercise test, the inability to independently use the cycle ergometer, the inability to follow the 
protocol instructions, uncontrolled arterial hypertension, any neurological condition other than 
HD, pregnancy or childbirth in the last 6 weeks, current and/or history of cardiac, vascular or 
respiratory/pulmonary conditions, illicit drug use in the last four weeks and any MRI 
contraindications. Data was collected with ethical approval from Wales Research Ethics 
Committee (15/WA/0074) and all participants gave informed consent according to the 
Declaration of Helsinki. All HD gene carriers were registered on a global longitudinal study of 
HD patients (ENROLL-HD; REC no. 04/WSE05/89) and had been examined on the UHDRS 
in the 6-month period prior to scanning thus the clinical and genetic data were available. 
Exercise Intervention  
The exercise intervention followed the procedures as described previously (Steventon et al., 
2019). Participants underwent 20-minutes of moderate-intensity aerobic cycling on an upright 
ergometer (Lode Ergometer, Lode, Groningen, Netherlands) at a prescribed intensity of 50-
70% of the maximal heart rate reserve (HRR) determined using the Karvonen formula 
(American College of Sports Medicine. et al., 2012). 
During upright rest, the warm up and warm down period, and at three-minute intervals during 
exercise, lactate concentration was collected, blood pressure was measured and self-report 
ratings of perceived exertion were recorded using a 10-point Borg scale (Borg, 1974). After 
20-minutes, participants completed a 2-minute warm down and then immediately returned to 
the MR scanner.  
MRI acquisition and image processing 
MRI of the brain was performed on a 3 T whole-body MRI system (GE Excite HDx, 
Milwaukee, WI, USA) equipped with a body transmit and eight-channel receive head coil.  
For the quantitative measurement of cerebral perfusion (ml/100g/min) at baseline and at three 
timepoints post exercise (Figure 1), a PICORE Pulsed ASL sequence was performed (Wong et 
al., 1997) with a gradient-echo spiral readout at eight inversion times (TI1-8 = 400, 500, 600, 
700, 1100, 1400, 1700, 2000ms, two separate scan series, echo time (TE) = 2.7 ms, TR = 
variable, 15 slices [7 mm thick + 1.5 mm gap], slice delay = 52 ms, FOV = 198 mm, 64 × 64 
matrix = ~ 3.1 mm2 in-plane resolution, 20cm tag width). A Quantitative Imaging of Perfusion 
with a Single Subtraction (QUIPSSII) (Wong et al., 1998) cut-off of the label was applied at 
700 ms for TIs > 700 ms. To estimate the equilibrium magnetization (M0) of arterial blood, a 
single echo spiral k-space scan was acquired with the same parameters as above, minus the 
ASL tag preparation. A minimum contrast scan (TE/TR = 11/2000 ms) was also acquired to 
correct for field inhomogeneity (Wu et al., 2011).  
A 3-dimensional T1-weighted fast spoiled gradient echo sequence was acquired at baseline and 
in the post-exercise scan session for image registration purposes (256 x 256, slice thickness = 
1 mm giving a resolution of 1mm3, TR/TE of 7.90/3.0 ms). 
At baseline and 20-minutes post exercise, a breath-hold challenge was performed to measure 
cerebrovascular reactivity (10 end-expiration breath-holds of 15s length interleaved with 30s 
periods of paced breathing) with a single-shot PICORE QUIPSS II pulse sequence (Wong et 
al., 1998). However, due to difficulties following the task instructions and poor performance 
of the breath-holds during acquisition, this data was not analyzed (see Supplementary Data). 
CBF quantification followed the procedures described by Steventon et al. (2019). Data were 
analysed in AFNI (Cox, 1996) and FSL (Jenkinson et al., 2012). Images were motion corrected, 
brain extracted and an M0CSF image was created following the procedures described by Warnert 
et al. (2015). The M0 for arterial blood was then calculated according to methods described by 
Wong et al. (1998) with CSF as a reference. Perfusion quantification was performed on a voxel-
by-voxel basis using a two-compartment model (Chappell et al., 2010) and employing partial 
volume correction (Chappell et al., 2011) to address signal contamination associated with 
atrophy.  
Median grey matter values were calculated for the four perfusion images (baseline, post-1, 
post-2, post-3) to assess global perfusion. Based on the exercise literature (Pereira et al., 2007; 
Smith et al., 2010; MacIntosh et al., 2014), regional changes in perfusion were assessed in a 
number of a priori defined regions of interest (ROIs): the thalamus (a key hub for the motor 
system), the hippocampus (evidence for exercise-induced neurogenesis and blood flow 
changes (van Praag et al., 2005; Pereira et al., 2007; Steventon et al., 2019), and three key 
cortical ROIs involved in sensorimotor processing - the middle frontal gyrus, postcentral gyrus, 
and precentral gyrus. Perfusion was also examined in the caudate, based on the hallmark striatal 
pathology in HD (Paulsen et al., 2010).  
ROIs were segmented from the T1-weighted image acquired in the same scan session and the 
median CBF values and arterial arrival time (AAT) - the time taken for blood to travel from 
the labelling slab to the tissue (Wang et al., 2003; Zappe et al., 2007), were calculated for each 
ROI. 
Cardiorespiratory measures 
Pulse waveforms and oxygen saturation were recorded (Medrad, PA, USA) and blood pressure 
measurements were collected using an arm-cuff before and after each scan (OMRON, Tokyo, 
Japan). Expired gas content was recorded (AEI Technologies, PA, USA) and sampled at 
500 Hz (CED, Cambridge, UK) to obtain measures of PETCO2. A respiratory belt was placed 
just below the ribs to monitor ventilation. Mean arterial pressure (MAP) was calculated as 
(systolic + 2* diastolic)/3. Supine resting heart rate and blood pressure were measured after 
15-minutes rest.  
Neuropsychological testing 
To capture any functional cognitive gains, participants were invited to complete ‘baseline’ 
cognitive tests on a separate day within 1 month of completing the MRI session, before or after 
to control for order effects. The post-exercise tests were completed immediately after the 
second MRI scan, at approximately 60-90 minutes after exercise cessation.  
Five pencil and paper tasks were used to measure cognitive functioning: [1] The Forward Digit 
Span (WAIS-IV) was used as a measure of verbal short-term memory. Participants were asked 
to repeat a digit sequence orally, beginning with two digits, and increasing in length by one 
digit following successful repetition of two lists of digits at a given length. [2] The letter verbal 
fluency test was used to assess verbal functioning. Participants were required to produce words 
beginning with a certain letter of the alphabet in three respective 60-s trials. [3] The Trail 
Making Test (part B) was used to measure visual attention, speed of processing, mental 
flexibility, and executive functions. Participants were presented with stimuli consisting of 
randomly placed numbers and letters and were required to connect the numbers of letters in 
sequence and alternating order (e.g. 1-A-2-B). [4] The Symbol Digit Modalities Test was used 
as a motor and psychomotor speed, with participants required to identify as many numbers [1-
9] corresponding to a set of symbols in a single 90-s. [5] The Speed of Comprehension subtest 
from the Speed and Capacity of Language Processing (SCOLP) test was used as a measure of 
processing speed; participants were required to determine if a list of sentences were correct or 
incorrect within a 2-minute period. As motor speed may confound performance on many of the 
cognitive tests, participants completed a computer-based Speeded Tapping Test (Reitan, 1979) 
with their dominant hand,  tapping the space bar as quickly as possible with their index finger. 
After 20 taps, the average number of taps per minute was calculated and averaged over three 
trials.  
Clinical and genetic predictor measures 
The motor component (total motor score; TMS) of the UHDRS provides a summed score of 
motor function including chorea, dystonia, motor impersistence, gait, rigidity, bradykinesia, 
finger tapping, and ocular movements. CAG repeat length was also used as a predictor.  
Baseline fitness test 
To measure baseline fitness, participants underwent an incremental cycle ergometer exercise 
test (1000W Cranlea, Human Performance Ltd, Birmingham, UK) on a separate day as 
described previously (Steventon et al., 2018). The test protocol consisted of 2 minutes of rest, 
2 minutes of unloaded cycling, followed by 25-watt increments every 2 minutes, starting at 50-
watts. The exercise test was symptom limited; individuals were instructed to pedal until 
discomfort or fatigue prevented them from maintaining the required cadence. Pulmonary gas 
exchange was measured on a breath-by-breath basis (MetaMax 3B, Cortex Biophysik GmbH, 
Leipzig, Germany), with the gas analyser calibrated before each session according to the 
manufacturer’s instructions. Heart rate was recorded continuously throughout using short-
range telemetry (Polar S810, Finland). Breath-by-breath data were averaged every 30-seconds 
and V̇O2 peak, the objective measure of cardiorespiratory fitness, was recorded as the average 
oxygen uptake across the final 15-seconds before the termination of the test. In addition, self-
reported physical activity levels were recorded using the International Physical Activity 
Questionnaire [IPAQ] (Craig et al., 2003).  
Statistical analyses 
An initial quality assessment examined any statistical outliers, defined as more than 3 standard 
deviations from the group mean, and removed them if found to be spurious (e.g. biologically 
implausible). To avoid biasing the results, all participants were included in the statistical 
analysis, including when missing data was present. A linear mixed effects model was used to 
assess change in cardiorespiratory physiology, cognition, and cerebral perfusion in a priori 
defined region of interests (ROIs) in R (version 1.1.463) (R Core Team, 2016) using the lme4 
package (Bates et al., 2015); between-subject effect: gene status [controls, HD], within-subject 
effect: time [baseline, post1, post2, post3] and hemisphere for perfusion analysis [left and 
right]; p-values were calculated from degrees of freedom estimated using Satterthwaite’s 
method (Kuznetsova et al., 2016). One advantage of a mixed effect model is the ability to 
estimate fixed effects from incomplete data (West and Galecki, 2012). For the perfusion 
analysis, PETCO2 and age were demeaned and included as covariates in the model along with 
sex. Post-hoc analyses examined HD and control participants separately to assess the effect of 
exercise.  
Where a significant gene effect on CBF was found, a follow up regression model was built 
from a set of a priori candidate predictor variables by entering and removing predictors based 
on Akaike Information Criteria, in a stepwise manner. The a priori predictors entered were a 
genetic predictor (CAG repeat length), a clinical predictor (UHDRS TMS), a performance-
related predictor (average heart rate reserve [HRR] achieved during the intervention), and a 
physiological predictor (PETCO2 change, known to modulate CBF).  
For the cognitive tests with a motor component (Trail Making, SCOLP, Symbol Digit 
Modalities Test), motor speed was included as a covariate in the analyses. Age was a covariate 
in all cognitive analyses. 
To compare performance and the physiological and perceptual response during the exercise 
intervention, heart rate, lactate, ratings of perceived exertion, work rate and cycling speed were 
averaged across the intervention period, excluding the warm up and warm down period, and 
compared between HD and control participants. All data are expressed as mean ± SEM unless 
stated.  
Data availability 
The CBF imaging data, physiological data, data analysis scripts and R code used for statistical 
analysis will be made available upon request for academic and non-commercial purposes. 
 
Results 
HD and control participants did not differ on gender, age, body mass index (BMI), fitness 
levels (measured using a VO2 peak test) and self-reported physical activity levels (all p > 
0.05, Table 1). Unadjusted values are shown in Supplementary Table 1. The cerebrovascular 
reactivity data was not analysed due to insufficient statistical power (see Supplementary 
Information).  
Physiological and self-reported response to the exercise intervention 
There was no difference on any of the heart rate (HR) metrics between control and HD 
participants during the intervention; the exercise intervention caused a significant increase in 
HR compared to the upright rest period on the ergometer in both control and HD participants 
(exercise effect, p < 0.001). Control participants worked at an average 54.8 ± 6.1 % of their 
maximum, calculated using HR reserve, compared to 54.8 ± 10.3 % for HD participants (gene 
effect, p = 0.99). Average HR did not differ across the intervention for controls (126.8 ± 2.8 
beats/min) and HD participants (127.2 ± 3.3 beats/min).  
Mean lactate concentration across the intervention did not significantly differ between control 
participants (2.87 ± 0.22 mmoL) and HD participants (2.23 ± 0.27 mmoL; p = 0.07). Mean 
self-reported ratings of exertion were associated with the verbal anchor ‘moderate’ to 
‘somewhat hard’ exertion on the Borg 0-10 RPE scale for both controls and HD participants in 
the legs (controls = 3.89 ± 0.22; HD = 4.25 ± 0.50, p = 0.53) and for breathing (controls = 3.38 
± 0.21; HD = 3.44 ± 0.42, p = 0.89). Results across the time course of the intervention are 
shown in Supplementary Figure 1. 
Despite no differences in the physiological or self-reported response to the intervention, HD 
participants cycled at a significantly lower workload (60.93 ± 5.09 watts) compared to controls 
(90.86 ± 4.77 watts, F 1,35 = 18.29, p < 0.001, η2 = 0.34), whereas there was no group difference  
in cycling speed (controls = 69.67 ± 2.45 revolutions/min; HD participants = 71.63 ± 3.03 
revolutions/min, p = 0.62).  
Mean HR, MAP and PETCO2 values for the baseline and post-exercise scan session are 
shown in Table 2. Exercise and gene did not interact on any measure (all p > 0.05). Exercise 
and gene status had a significant main effect on HR; HD participants’ HR was 7.77 ± 3.61 
beats/min higher compared to controls (p=0.037). After the exercise session, HR remained 
elevated across both groups at 15-minutes (+7.88 ± 1.23 beats/min, p = 5.23e-09), and 40-
minutes post exercise (+2.50 ± 1.18 beats/min, p = 0.037), before returning to baseline levels 
after 60-minutes (+1.46 ± 1.21 beats/min, p = 0.22).  
Exercise and gene status had no effect on MAP, with no evidence of exercise-induced 
hypotension when the post-exercise scan session began (p > 0.05). 
PETCO2 levels were similar for HD and control participants, and exercise-induced 
hypocapnia was observed across both groups of participants and persisted for 60-minutes post 
exercise, with a significant reduction in PETCO2 from baseline at 15-minutes (t88.5 = -2.48, p = 
0.015), 40-minutes ( t88.5 = -2.96, p = 0.004) and 60-minutes post exercise ( t88.3 = -2.19, p = 
0.03), see Figure 2H.  
Regionally-specific effects of exercise on blood flow in HD  
Absolute CBF values (estimated marginal means adjusted for age, sex and end-tidal CO2) are 
reported in Table 2; the change in cerebral blood flow (CBF) from baseline is shown in Figure 
2 for the three post exercise time points.  
Globally, exercise (p=0.80) and gene status (p=0.73) had no effect on grey matter CBF. A gene 
status x exercise interaction was found in the middle frontal gyrus and precentral gyrus; forty 
minutes after exercise cessation the exercise-induced CBF change from baseline was 13.67 ± 
6.75 ml/100g/min higher in HD patients in the middle frontal gyrus (t81.8 = 2.03, p = 0.046, 
Figure 2B) and 14.12 ± 5.71 ml/100g/min higher in the precentral gyrus in HD participants 
compared to controls (t81.1 = 2.47, p = 0.016, Figure 2C). Post-hoc analyses found the change 
in CBF relative to baseline in the precentral and middle frontal gyrus was significant in the HD 
participants (precentral increase = 11.73 ± 4.36 ml/100g/min, p = 0.010, MFG increase = 14.88 
± 5.65 ml/100g/min, p = 0.012), whereas the change was not significant in control participants 
(precentral decrease = -4.61 ± 4.33, p =0.29, MFG decrease = -2.25 ± 4.53, p =0.62).  
Controls and HD participants did not differ in precentral and middle frontal gyrus CBF at 
baseline (p = 0.60 and 0.32 respectively), 15-minutes post exercise (6.20 ± 5.52 and 2.60 ± 
6.54 ml/100g/min respectively) and 60-minutes post exercise (6.77 ± 5.96, and 0.89 ± 7.03 
ml/100g/min; all p > 0.05). Exercise and gene status had no effect on CBF values in the 
postcentral gyrus. 
In the subcortical ROIs, hippocampal CBF was 5.12 ± 2.45 ml/100g/min higher 60-minutes 
post exercise across all participants (t205 = 2.07, p = 0.039). Additionally, an interaction between 
exercise and gene status was found (F3,198 = 3.05, p = 0.03); at 40-minutes post exercise, the 
exercise-induced CBF change was significantly different between HD and control participants 
(6.98 ± 3.51 ml/100g/min; t200 = 1.99, p = 0.048, see Figure 2G). Post-hoc analysis found this 
was driven by a significant increase in hippocampal CBF in HD participants 40-minutes after 
exercise cessation (+6.53 ± 3.15 ml/100g/min, p = 0.04), whereas there was no significant 
change in control participants at this time (1.28 ± 2.30, p = 0.58). Baseline hippocampal CBF 
did not differ between controls and HD participants (t68 = 0.12, p = 0.90). 
Exercise and gene status had no effect on CBF in the thalamus or caudate, and no effect on 
arterial arrival time (AAT) averaged across the grey matter or in any of the ROIs (all p > 0.05, 
Supplementary Table 1).  
Predictors of the exercise-induced CBF response  
VO2 peak was not correlated with baseline cerebral blood flow in grey matter or in the ROIs 
and gene status did not affect the relationship (all p > 0.05).  
A regression model examined the predictors of the observed perfusion changes seen 40-
minutes after exercise cessation; the scaled estimates for each predictor in the model for HD 
and control participants are shown in Figure 3. 
In HD participants, HRR, PETCO2 change and TMS were entered into the regression model 
and explained 68.2% of the variance in exercise-induced CBF change in the hippocampus (p = 
0.0001). HRR explained 42.8% of the variance alone (β = -148.8, p < 0.001), whilst PETCO2 
and TMS were non-significant predictors (β = -0.62 and -0.35, p = 0.129 and 0.086 
respectively).  
 In the precentral gyrus, 57% of the variance in CBF change was explained by the model which 
included CAG repeat length (β = -4.17, p = 0.031), PETCO2 change (β = 2.38, p = 0.022) and 
HRR during the intervention (β = -1.62, p=0.97). The clinical predictor (TMS) did not meet 
the criteria for entry into the model.  
In the MFG, PETCO2 change (β = 3.20, p = 0.06), CAG repeat length (β = -4.26, p =0.16), and 
HRR (β = 17.26, p = 0.80) explained 29.1% of the CBF variance and the model was not 
significant (p=0.18). 
 
In control participants at the same timepoint 40-minutes post exercise cessation, HRR and 
PETCO2 were not predictive of hippocampal CBF change (adjusted R2 = 0.05, p = 0.20), MFG 
CBF change (adjusted R2 = -0.13, p = 0.76) or precentral CBF change (adjusted R2 = -0.08, p 
= 0.62).  
Cognitive performance is impaired following acute exercise 
Cognitive test performance is shown in Table 3; HD participants performed worse on all 
cognitive tests (main effect of gene status, all p < 0.05) and had a significantly slower motor 
tapping speed compared to controls (F1,33 = 17.06, p = 0.0002).  
A main effect of exercise was found for performance on the Stroop interference task (p = 
0.002), symbol digits modality test (p = 0.007) and speed of comprehension SCOLP test 
(p=0.003), with worse performance observed following the exercise intervention compared to 
baseline (see Table 3). There was no interaction between the effect of exercise and gene status. 
Discussion 
Long-term exercise interventions improve motor functioning in people with HD (Khalil 
et al., 2013; Quinn et al., 2016; Fritz et al., 2017) although the underlying mechanism is poorly 
understood. Here, using a highly controlled acute exercise paradigm, we aimed to characterise 
the cerebrovascular response to a single session of aerobic exercise in people with HD using 
arterial spin labelling (ASL)-MRI. Our data showed twenty-minutes of moderate intensity 
cycling induced a transient regionally-selective cerebral perfusion response that was different 
in HD participants compared to control participants. Whilst exercise induced a non-significant 
negative change in cerebral blood flow (CBF) in control participants in the precentral and 
middle frontal gyri, a significant increase in CBF was observed in HD participants 40-minutes 
after exercise cessation. Likewise, in the hippocampus, an area previously shown to be 
selectively responsive to acute exercise (Steventon et al., 2019), CBF was significantly 
elevated 40-minutes after exercise in HD participants compared to controls. We further 
observed an increase in hippocampal blood flow 60-minutes after exercise cessation in both 
controls and HD participants, in line with previous work (Steventon et al., 2019).  
The differential effect of exercise on cerebral perfusion in HD participants compared 
to controls was hypothesised based on an altered cardiovascular response to exercise 
(Steventon et al., 2018) and resting cerebrovascular abnormalities (Drouin-Ouellet et al., 
2015), however the direction of perfusion effects in HD participants was not anticipated, with 
an increase in CBF generally interpreted as beneficial in healthy cohorts. However, as an 
increase in CBF was not also seen in controls, the cerebrovascular response more likely reflects 
a latent pathology induced by exercise in HD participants. In support of this, cerebral hyper-
perfusion has been documented previously in HD patients and animal models, observed as 
increased vessel density, increased cerebral blood volume and flow, increased blood brain 
barrier permeability and greater release of VEGF-A, an angiogenic growth factor, by astrocytes 
(Vis et al., 1998; Harris et al., 1999; Wolf et al., 2011; Chen et al., 2012; Franciosi et al., 2012; 
Lin et al., 2013; Hua et al., 2014; Hsiao et al., 2015). Increased angiogenesis coupled with a 
reduced number of pericytes and altered vascular reactivity has been observed in HD mice 
(Hsiao et al., 2015), suggesting a complex functional impairment which may impact 
neurovascular coupling and thus the cerebrovascular response to exercise  
The regional specificity of the exercise effects are particularly noteworthy and partly in 
agreement with previous work in young adults and stroke patients (MacIntosh et al., 2014; 
Robertson et al., 2015; Steventon et al., 2019), suggesting the observed effects are specific to 
the exercise intervention in the HD group.  Moreover, CAG repeat length, a key factor in HD 
pathogenesis, was predictive of the cerebrovascular response to exercise in the precentral 
gyrus, with a larger post-exercise increase in CBF observed in participants with a lower CAG 
repeat length. The precentral gyrus, also known as the primary motor cortex, is a vital structure 
involved in executing voluntary motor movements and capable of cortical functional 
reorganisation (Wall et al., 2002; Lee et al., 2003) and acute compensatory plasticity, with 
changes in functional organisation demonstrated over minutes, weeks, and longer durations 
(Wall et al., 2002; Lee et al., 2003; Weiss et al., 2004; Björkman et al., 2009). The regional 
effects were not explained by baseline resting hypo- or hyper-perfusion in the HD participants, 
however previous work has shown significant cortical thinning and locally decreased task 
related fMRI activation in both the middle frontal and precentral gyri in HD participants (Wolf 
et al., 2007, 2008; Rosas et al., 2008; Saft et al., 2008). This supports the concept that the 
regionally-selective effect in HD participants and not controls are due to underlying vascular 
alterations in HD, which convey an increased propensity for exercise-induced vascular 
adaptions. However, increased connectivity has been observed using resting-state fMRI in the 
precentral gyrus in pre-manifest HD. This could alternatively suggest regional compensatory 
changes occur in brain connectivity early on in HD(Koenig et al., 2014), and the observed 
relationship observed with CAG length suggesting the capacity for compensatory changes is 
dependent on genetic burden. Further research is warranted to test whether the observed 
increase in CBF could reflect a compensatory mechanism to support neuronal survival, as 
certain regions may be less vulnerable to hindered cerebral haemodynamics in individuals with 
a lower genetic load.  
The regulation of CBF is controlled by neurogenic, metabolic, autoregulatory and 
systemic factors; exercise-induced changes in CBF may be accounted for by changes in some 
or all of these in HD participants. However, the temporal pattern of cardiorespiratory recovery 
after exercise cannot explain our results; heart rate, blood pressure and the end-tidal partial 
pressure of carbon dioxide (PETCO2) were not differentially affected by exercise in HD and 
control participants. In both groups, blood pressure recovered to baseline levels prior to the 
post exercise scans and heart rate was elevated during both the 15- and 40-minutes post exercise 
scan, whereas a CBF difference was only observed at 40-minutes. PETCO2 remained 
significantly lower than baseline at all three post-exercise timepoint, and because PETCO2 is 
known to modulate arteriolar diameter (Thomas et al., 1989; Ide and Secher, 2000; Ratanakorn 
et al., 2001) it was accounted for in the statistical model, and predicted the CBF change in the 
precentral gyrus in HD participants. However, this is unlikely to explain the differences seen 
between controls and HD participants; the magnitude of PETCO2 change did not differ between 
the two groups and PETCO2 did not account for the changes observed in the hippocampus and 
middle frontal gyrus. In a healthy vascular system, hypocapnia (observed here following 
exercise) causes an increase in cerebral vasoconstriction, therefore a reduction in CBF would 
be expected, rather than the observed increase in CBF seen in HD participants. However, 
impaired vascular reactivity to haemodynamic challenges has been shown in preclinical HD 
models, with a smaller increase in CBF following carbogen in HD mice compared to wild 
types, despite greater vessel density (Hsiao et al., 2015). Thus, the observed increase in CBF 
after exercise in HD patients may be due to a blunted hypocapnic response in HD participants, 
although the results from the regression model do not support this in all of the regions affected. 
We intended to measure the CBF response to hypercapnia in this study to test this hypothesis, 
however the breath-hold paradigm we utilised was limited by highly variable and poor task 
performance in both groups and thus requires further optimisation before a robust measure of 
cerebrovascular reactivity can be obtained.  
 
The temporal specificity of our results is particularly novel, with a difference between 
HD and controls observed 40-minutes after exercise cessation, but not at 15- and 60-minutes 
post exercise. One explanation for the CBF difference is a lag effect from the CVR breath-hold 
challenge, performed immediately before the 40-minute CBF scan, as during breath-holding, 
the increase in the partial pressure of CO2 gives rise to increased CBF because of vasomotor 
reactivity. However, this is unlikely due to poor performance in both groups, with CO2 
increasing after a breath-hold on only half of the trials. More likely, it suggests there is a 
temporal window for acute exercise effects which may be driven by resting vascular 
perturbations in the HD participants. In support of this, work in stroke patients also show a 
transient time-dependent CBF response to exercise in distinct brain regions, with a reduction 
in CBF in the middle frontal gyrus observed 30-minutes post exercise, and returning to baseline 
by 50-minutes (Robertson et al., 2015).  
Designing an exercise intervention to be physically and perceptually similar for the 
patient and control group was challenging given that HD patients have an altered metabolic 
and cardiorespiratory response to submaximal exercise (Steventon et al., 2018). Nevertheless, 
we achieved an equivalent moderate-intensity aerobic intervention with no difference in the 
peripheral physiological response or self-reported exertion, suggesting that the observed effects 
in HD are not due to a difference in intervention prescription. However, HD participants on 
average cycled at a lower workload to achieve the prescribed target heart rate, most likely due 
to an altered movement economy. The exercise intensity achieved by HD participants during 
the intervention predicted the hippocampal perfusion response, which may indicate that unlike 
the cortical regions, the exercise-induced hippocampal effect is intensity-dependent. It is 
plausible that cardiovascular changes observed in preclinical models and clinical HD(Wood et 
al., 2012; Buonincontri et al., 2014; Bellosta Diago et al., 2018; Steventon et al., 2018) may 
mediate the altered cerebral response observed. HD participants were found to have a higher 
heart rate across the study compared to controls, although no interaction effect was found with 
exercise. Future studies would combine comprehensive cardiovascular and cerebrovascular 
measures to investigate vascular impairments in HD in response to exercise.  
 
An additional consideration is that exercise is a potent physiological stimulus upon the 
hypothalamo-pituitary adrenal (HPA) axis. There is evidence that the HPA axis is impaired in 
HD (Kassubek et al., 2004; Petersén et al., 2005; Björkqvist et al., 2006; Soneson et al., 2010; 
van Wamelen et al., 2014), with mixed evidence of subtle alterations in neuroendocrine 
signalling, including cortisol (Aziz et al., 2009; Kalliolia et al., 2015). Equivocal evidence for 
a modulating effect of cortisol on CBF (Hodkinson et al., 2014; Schilling et al., 2014; Handley 
et al., 2016) is sufficient to merit future exercise studies in HD collecting neuroendocrine 
measures along with cardiorespiratory data.  
Functional improvements in cognition have been reported following long-term exercise 
interventions in healthy cohorts (Dustman et al., 1984; Kramer et al., 1999) as well as in 
Parkinson’s disease (Duchesne et al., 2015; Altmann et al., 2016) and Alzheimer’s disease 
(Ströhle et al., 2015; Teixeira et al., 2018). In this study, cognitive performance approximately 
one-hour after exercise cessation was worse than at baseline in HD and control participants 
alike, most likely due to fatigue associated with the lengthy testing session, rather than a direct 
effect of exercise. Whereas baseline cognitive tests were completed at the beginning of the 
experimental session on a separate day, the post-exercise testing was conducted approximately 
3.5 hours into the experimental session. Cognitive data were a secondary outcome measure; it 
is plausible that transient cognitive gains returned to baseline levels by the time of testing, with 
the study not optimally designed to examine transient cognitive effects and appropriately 
control for fatigue. We were also likely underpowered to detect an effect, with acute gains in 
cognition previously reported with small effect sizes (Chang et al., 2012).  
 A limitation of our study is the heterogeneity of the HD group, which includes 
presymptomatic and manifest gene carriers. Therefore, we were unable to identify at what stage 
in the disease an altered response to exercise occurs. Future work in a pre-symptomatic group 
is required to provide insight into whether the observed exercise-induced brain changes are 
causally involved in early pathogenesis of HD. 
Conclusions 
Overall, we observed a differential response to a single session of exercise in HD and 
control participants, with a transient regionally-selective increase in perfusion in HD 
participants. The highly controlled acute exercise paradigm used may provide a framework for 
determining the key components that enable exercise to modulate a pathologically disturbed 
cerebrovasculature for therapeutic gain in HD. Further work is necessary to understand the 
extent and pattern of disruptions to the neurovascular unit in HD to inform the development of 
targeted exercise approaches. 
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Legends for figures  
 
 
FIGURE 1 STUDY DESIGN. MRI MEASURES WERE RECORDED UP TO 65-MINUTES AFTER EXERCISE CESSATION. ASL: 
ARTERIAL SPIN LABELLING MRI. T1-W: T1-WEIGHTED STRUCTURAL MRI SCAN ACQUIRED FOR IMAGE REGISTRATION 
PURPOSES. CYCLING WAS PERFORMED ON AN UPRIGHT ERGOMETER. * A SCAN TO MEASURE CEREBROVASCULAR 
REACTIVITY (CVR) USING A BREATH-HOLD DESIGN WAS ACQUIRED BUT NOT ANALYSED DUE TO POOR PERFORMANCE.  
 
 
FIGURE 2 ABSOLUTE CHANGE IN CEREBRAL BLOOD FLOW (CBF) AND END-TIDAL CO2 (BOTTOM RIGHT PANEL) FROM 
BASELINE, MEASURED AT 15-, 40-, AND 60-MINUTES FOLLOWING EXERCISE CESSATION. DATA SHOWN ARE THE 
MARGINAL MEANS ADJUSTED FOR PETCO2, SEX AND AGE. ERROR BARS REPRESENT THE STANDARD ERROR OF THE 
MEAN. MFG: MIDDLE FRONTAL GYRUS * P < 0.05 GENE EFFECT. † P < 0.05, †† P < 0.01 MAIN EFFECT OF EXERCISE. 
 
FIGURE 3. LINEAR MODEL PREDICTORS OF PERFUSION CHANGE 40-MINUTES AFTER EXERCISE CESSATION. HRR: HEART 
RATE RESERVE DURING EXERCISE. TMS: TOTAL MOTOR SCORE. SCALED COEFFICIENT ESTIMATES, 95% CONFIDENCE 
INTERVALS AND COEFFICIENT OF UNCERTAINTY SHOWN. RESULTS OF STEPWISE REGRESSION FOR PREDICTORS: * P 
<0.05, *** P < 0.001 
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TABLE 1 SOCIODEMOGRAPHIC, FITNESS, GENETIC AND CLINICAL DATA FOR HD AND CONTROL PARTICIPANTS. MEAN ± 
STANDARD ERROR MEAN (RANGE). ONE-WAY ANOVA OR CHI-SQUARED TESTS WERE USED TO COMPARE HD 
PATIENTS TO CONTROLS. IPAQ: INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE. MAP: MEAN ARTERIAL 
PRESSURE.  
  HD (n = 19)   
Healthy controls 
(n=19) 
 p-
value  
Gender (male, N) 13  10 0.32 
Age 45.9 ± 2.2 (32-65)  42.2 ± 2.1 (29-63) 0.23 
BMI 26.2 ± 1.3 (18-40)  27.6 ± 0.9 (22-40) 0.41 
IPAQ 
2723.2 ± 847.1 (0-
10755)‡ 
 
2807.4 ± 682.8 (396-
13488) 
0.94 
VO2 peak (ml/kg/min) 34.6 ± 2.5 (18-50)  37.4 ± 2.3 (25-61) 0.42 
MAP (mmHg)† 92.70 ± 2.07  88.06 ± 2.77 0.19 
CAG repeat length 43.7 ± 0.6 (41-50)  
N/A   
Disease burden  
[(CAG lengthn-35.5) x age] 
370.3 ± 24.4 (208-575)  
UHDRS Total Motor 
Score 
25.7 ± 4.4 (0-68)  
UHDRS composite score 
(Schobel et al., 2017) 
12.13 ±1.19 (2.8-18.6) 
 
  
UHDRS Total 
Functioning Capacity  
10.2 ± 0.8 (3-13)   
† Rest measures calculated after 15-minutes supine rest. ‡ One HD participant had an 
extreme high IPAQ score (353512) that was removed from the group mean data to avoid 
skew. 
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TABLE 2 ESTIMATED MARGINAL MEANS (± S.E.M) AFTER ADJUSTING FOR PETCO2, AGE AND SEX FOR 
CARDIORESPIRATORY AND CEREBROVASCULAR MEASURES AT BASELINE AND AFTER 20-MINUTES OF MODERATE 
INTENSITY EXERCISE. CON= HEALTHY CONTROLS. DATA IN BOLD REPRESENT A SIGNIFICANT EFFECT OF EXERCISE IN 
POST-HOC ANALYSES.  
 
  Baseline 
  Post exercise scan session 
 
  Post 1 Post 2 Post 3  
 CON HD  CON HD CON HD CON HD 
Cardiorespiratory measures 
HR, 
beats/min 
62.0 ± 
2.2 
69.8 ± 
2.6 
 
69.9 ± 
2.7 
77.8 ± 
2.5 
65.2 ± 
2.2 
72.2 ± 
2.1 
64.5 ± 
2.6 
74.2 ± 
2.7 
MAP, mmHg 
87.5 ± 
2.2 
92.7 ± 
2.1 
 
86.9 ± 
2.5 
90.2 ± 
2.3 
87.2 ± 
3.0 
89.9 ± 
2.9 
87.9 ± 
2.8 
92.5 ± 
2.6 
PETCO2, 
mmHg 
36.2 ± 
1.2 
34.7 ± 
1.4 
 
34.4 ± 
1.2 
31.6 ± 
1.3 
34.0 ± 
1.2 
30.3 ± 
1.7 
34.6 ± 
1.1 
32.0 ± 
1.5 
Perfusion (ml/100g/min) in ROIs 
Grey matter 
52.8 ± 
2.9 
51.5 ± 
3.2 
 
53.3 ± 
3.0 
55.6 ± 
3.2 
50.2 ± 
3.0 
56.1 ± 
3.4 
52.0 ± 
3.0 
53.5 ± 
3.4 
Middle 
frontal gyrus 
43.4 ± 
4.2 
38.8 ± 
4.5 
 
43.5 ± 
4.4 
41.5 ± 
4.6 
42.3 ± 
4.4 
51.4 ± 
5.1 
42.8 ± 
4.6 
39.1 ± 
5.1 
Postcentral 
gyrus 
51.0 ± 
4.7 
48.5 ± 
5.0 
 
52.7 ± 
4.8 
54.9 ± 
5.2 
51.4 ± 
4.8 
60.9 ± 
5.6 
55.0 ± 
4.9 
54.1 ± 
5.7 
Precentral 
gyrus 
54.4 ± 
4.1 
51.7 ± 
4.4 
 
52.8 ± 
4.2 
56.3 ± 
4.5 
50.2 ± 
4.2 
61.6 ± 
4.9 
51.5 ± 
4.4 
55.5 ± 
4.9 
Caudate  
31.6 ± 
3.1 
24.3 ± 
2.3 
 
29.7 ± 
2.3 
26.1 ± 
4.2 
29.7 ± 
2.9 
26.1 ± 
2.5 
37.0 ± 
6.8 
25.7 ± 
3.4 
Thalamus  
49.5 ± 
4.8 
41.1 ± 
3.6 
 
49.1 ± 
3.4 
42.8 ± 
4.4 
45.8 ± 
4.4 
46.3 ± 
5.0 
41.7 ± 
3.1 
40.7 ± 
4.4 
Hippocampus 
51.0 ± 
4.7 
48.5 ± 
5.0 
  
52.7 ± 
4.8 
54.9 ± 
5.2 
51.4 ± 
4.8 
60.9 ± 
5.6 
55.0 ± 
4.9 
54.1 ± 
5.7 
 
Exercise MRI in Huntington’s Disease 
Steventon et al. 
 
TABLE 3 COGNITIVE PERFORMANCE AT BASELINE AND APPROXIMATELY 75-MINUTES AFTER EXERCISE CESSATION. 
MEANS ± S.E.M. DATA ARE MARGINAL MEANS ADJUSTED FOR AGE, AND FOR THE SYMBOL DIGIT SCORE, SCOLP AND 
TRAIL MAKING, ALSO ADJUSTED FOR MOTOR SPEED. 
  Controls    HD   
FDR-adjusted p 
values 
 Baseline 
Post 
exercise 
 Baseline 
Post 
exercise 
 Exercise 
Gene 
Status 
Symbol 
digit score  
61.3 ± 
2.9 
57.2 ± 
3.0 
 
41.8 ± 
3.1 
40.4 ± 
3.2 
 0.015 0.0004 
SCOLP  
84.5 ± 
4.8 
78.6 ± 
4.9 
 
52.1 ± 
5.1 
50.1 ± 
5.2 
 0.012 0.0004 
Digit Span 
(raw) 
11.7 ± 
0.5 
11.8 ± 
0.6 
 
9.7 ± 
0.6 
9.1 ± 
0.6 
 0.3 0.004 
Trail 
Making (s) 
44.7 ± 
11.7 
51.3 ± 
12.2 
 
96.9 ± 
11.8 
106.8 ± 
13.1 
 0.14 0.0053 
Verbal 
Fluency 
17.8 ± 
1.2 
15.5 ± 
1.2 
 
9.7 ± 
1.2 
10.3 ± 
1.2 
 0.26 0.0004 
 (1 letter) 
Stroop 
Interference 
50.1 ± 
3.1 
44.8 ± 
3.1 
 
36.0 ± 
3.13 
33.2 ± 
3.1 
 0.012 0.005 
Motor 
Speed 
(taps/min) 
452 ± 
20.9 
459 ± 
21.3 
  
337 ± 
21.4 
331 ± 
21.3 
  0.96 0.0004 
 
 
 



